or1ega9r的部落格

A patentable excogitation is an innovation that is "novel" lower than 35 U.S.C.A. § 102, "useful" under 35 U.S.C.A. § 101, and "nonobvious" lower than 35 U.S.C.A. § 103. Section 103(a) of the Patent Act sets off the constant quantity of the noticeableness requirement:

A official document may not be obtained tho' the creativeness is not identically disclosed or delineate as set off in Section 102 of this title, if the differences linking the concern business wanted to be patented and the prior art must not be such as that the concern business as a full would have been self-explanatory at the juncture the design was ready-made to a personage having middling elegance in the art to which aforementioned idea substance pertains.

In Graham v. John Deere Co., 383 U.S. 1, 17 (1966), the United States Supreme Court interpreted this communication to imply that the last willpower on the dynamic of patency is fumed as a question of law but is supported on real inquires that see (1) the range and contented of the antecedent art; (2) the differences between the antecedent art and the claimed invention; (3) the smooth of talent in the art; and (4) the neutral documentation of non-obviousness.

To get your hands on a rights on a new natural science compound, the even-pinnate must just the nonobviousness duty at the instance it is made-up. Special issues, however, originate beside chemic patents because unlike electrical and mechanical sciences, natural science is an explosive art. Minor changes in structures can dramatically feeling a compound's properties. Thus, it is inherently tight for a tribunal to make certain the noticeableness of a claimed imparipinnate near a correspondent structure to that of a anterior art.

The degree of the confront to establish the conspicuousness of natural science compounds can be illustrated by the issues two-faced by the judicature in Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, 231 F.3d 1339 (Fed. Cir. 2000). In Yamanouchi, the battle central on whether one talented in the art would have thoughtful it self-evident to clear the pills Famotidine by (1) union the polar appendage from head quinquefoliate 44 near the adapted heterocycle from Tiotidine to genre an gray compound, and (2) work the carbamoyl pressure group in the next-to-last ternate beside a sulfamoyl faction to bring into being Famotidine as shown downwards in Scheme 1. It was powerfully noted that some Tiotidine and Tagamet were antecedent compounds, of which Tagamet was a palmy medication in marketplace deposit time Tiotidine spoilt in preclinical trials due to its high toxicity. Both compounds, however, showed dignified efficaciousness as inhibitors of internal organ sulphurous secretion.

The tribunal in Yamanouchi upheld the government grant antagonistic an assertion of noticeability. Id. at 1345. The committee explained, "For a natural science compound, a stellar facie casing of conspicuousness requires a showing of 'structural identicalness between claimed and antecedent art question situation ... where the anterior art gives pretext or motivation to gross the claimed compositions.'" Id. at 1343 (quoting In re Dillon, 919 F.3d 688, 692 (Fed. Cir. 1990)). Even in spite of this the claimed pinnate substandard the testing of structural similarity, the Yamanouchi trial invalid a leading facie travel case of patency supported on a paucity of psychological feature to jumble the antecedent art to brand the claimed invention beside the same natural control to that of the preceding art.

A. Structural similarity

Structural sameness linking chemic compounds has effectively created a exceptional and annoying field of rights law. In re Jones, 958 F.2d 347, 350 (Fed. Cir. 1992). In decisive the conspicuousness of a time-honoured chemical compound, courts in earlier times persistent on the correspondence linking the structures of a claimed tripinnate and that of a pinnate unveiled in the preceding art. In re Hass, 141 F.2d 122 (C.C.P.A 1944); In re Henze, 181 F.2d 196 (C.C.P.A. 1950).

In Hass, the claimed tripinnated was a homolog of a antecedent art bilobate (Scheme 2). See Hass, 141 F.2d at 125. There was lone one more than atomic number 6 section in the claimed trilobated than that in the antecedent art. The Court of Claims and Patent Appeals control that the claimed incised was not patentable unless it disclosed "some nonobvious or unheralded advantageous properties not possessed by the homologous trilobate unveiled in the prior art." Id. The general ideology aft the court's edict was that chemical and somatogenetic properties come and go single a tad involving members of a homologous ordering. Id. The Henze case transformed this generalisation into a presumption that was rebuttable if the person showed "that the claimed pedate possesses unprovable or unhoped-for useful properties not in reality possessed by the prior art homologues." In re Henze, 181 F.2d at 201. Clearly both courts perceived natural science support and chemic properties as two different considerations. Therefore, for structurally siamese chemic homologues, a new quinquefoliate was deemed star facie perceptible because a chemist could trust or project that the new chemical lobed would have the one and the same properties in a specified complex as did a connatural anterior art merged.

B. Inseparable support and its properties

After sector 103 was enacted, courts at a snail's pace emotional to a more than holistic spectacle of chemic compounds that considered chemic properties in accessory to natural science structures. In re Papesch, 315 F.2d 381 (C.C.P.A. 1971). In ­Papesch, an petitioner claimed a relations of compounds together with sales rep decompound 2,4,6-triethylpyrazolo(4,3-d)-4,5,6,7-tetrahydropyrimidine-5,7-dione (ethyl = CH2CH3), which was admittedly "structurally obvious" in restrained of a claimed palm-shaped 2,4,6-trimethylpyrazolo(4,3-d)-4,5,6.7-tetrahydropyrimidine-5,7-dione (methyl = CH3) as shown in Scheme 3. Id. at 384.

Comparative tests of the trimethyl multipart and the applicant's triethyl palmatifid showed that the latter was an active anti-inflammatory drug agent piece the anterior art parted was flattering at leisure for that utility-grade. The Papesch committee explicit that the properties of compounds were in dispute to obviousness, action that the creative thinking as a total was a tripinnated beside its own properties. Id. at 390. Additionally, the committee found that proof of non-obvious or unexpectedly positive properties not mutual by the antecedent art trilobed may repudiate a major facie legal proceeding of noticeableness. Id. at 391.

A compound and all of its properties are inseparable; they are one and the very point .... But a technique is not a trilobed and time it may spoon over in a charge to personality what is anyone patented, as the metes and bounds of a achievement set a scheme of land, the article that is patented is not the instructions but the bilobated identified by it. And the patentability of the point does not depend on the likeness of its formula to that of another combined but of the equivalence of the former bilobed to the latter. There is no font in law for ignoring any chattels in making such a comparing. Id.

Thus the board attractively driven natural science government grant applications as long-dated as a claimed invention could give you an idea about new properties even then again the claimed trifoliate joint a siamese support near a antecedent art abruptly-pinnate. The Papesch court, however, did not matter near the requirements for establishing a stellar facie shield of conspicuousness. The committee only command that, for cases next to a supposition of obviousness, an assessor had to view both the properties of the invention and the knowledge correlation. Id.